相似文献
1
Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.
J Diabetes Complications. 2021 Apr;35(4):107841. doi: 10.1016/j.jdiacomp.2020.107841. Epub 2020 Dec 31.
2
Clinical challenges in diagnosis and management of diabetic kidney disease.
Am J Kidney Dis. 2014 Feb;63(2 Suppl 2):S3-21. doi: 10.1053/j.ajkd.2013.10.050.
3
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2.
4
Diabetic Kidney Disease.
Prim Care. 2020 Dec;47(4):645-659. doi: 10.1016/j.pop.2020.08.004. Epub 2020 Sep 23.
5
An integrative systems biology approach for precision medicine in diabetic kidney disease.
Diabetes Obes Metab. 2018 Oct;20 Suppl 3(Suppl 3):6-13. doi: 10.1111/dom.13416.
6
Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Clin Sci (Lond). 2019 Jun 20;133(12):1321-1339. doi: 10.1042/CS20190372. Print 2019 Jun 28.
7
Diagnosis and treatment of diabetic kidney disease.
Am J Med Sci. 2014 May;347(5):406-13. doi: 10.1097/MAJ.0000000000000185.
8
Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.
J Diabetes Investig. 2017 May;8(3):261-271. doi: 10.1111/jdi.12624. Epub 2017 Mar 13.
9
Sex and Gender Related Differences in Diabetic Kidney Disease.
Semin Nephrol. 2022 Mar;42(2):170-184. doi: 10.1016/j.semnephrol.2022.04.007.
10
The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps.
Curr Diab Rep. 2019 Mar 2;19(4):18. doi: 10.1007/s11892-019-1133-6.
引用本文的文献
1
Nocturnal hypoxemic burden is associated with worsening prognosis of chronic kidney disease in patients with type 2 diabetes.
Cardiovasc Diabetol. 2025 Aug 31;24(1):354. doi: 10.1186/s12933-025-02918-y.
2
BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells.
Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06519-y.
3
Nedd4-2 ablation in kidney improves glycaemic control in diabetic mice.
Cell Death Dis. 2025 Jul 5;16(1):496. doi: 10.1038/s41419-025-07826-3.
4
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.
Diabetes Ther. 2025 Jun 4. doi: 10.1007/s13300-025-01750-7.
5
Longitudinal Estimated Glomerular Filtration Rate Trajectories in Children with Type 1 Diabetes.
Pediatr Diabetes. 2023 Jun 29;2023:6648920. doi: 10.1155/2023/6648920. eCollection 2023.
6
Trends and future predictions of chronic kidney disease due to diabetes mellitus type 2 attributable to dietary risks: insights based on GBD 2021 data.
Front Nutr. 2025 Jan 13;11:1494383. doi: 10.3389/fnut.2024.1494383. eCollection 2024.
7
Sex-specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors.
FASEB J. 2024 Dec 13;38(24):e70270. doi: 10.1096/fj.202402354R.
8
Embracing sex-specific differences in engineered kidney models for enhanced biological understanding of kidney function.
Biol Sex Differ. 2024 Dec 2;15(1):99. doi: 10.1186/s13293-024-00662-8.
9
Effect of poor glycemic control on the prevalence and determinants of anemia and chronic kidney disease among type 2 diabetes mellitus patients in Jordan: An observational cross-sectional study.
PLoS One. 2024 Nov 14;19(11):e0313627. doi: 10.1371/journal.pone.0313627. eCollection 2024.
10
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.
Diabet Med. 2025 Feb;42(2):e15447. doi: 10.1111/dme.15447. Epub 2024 Oct 26.
本文引用的文献
1
Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver.
Nat Rev Endocrinol. 2021 Jan;17(1):47-66. doi: 10.1038/s41574-020-00431-8. Epub 2020 Nov 10.
2
Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey.
Diabetes Care. 2020 Jun;43(6):1227-1233. doi: 10.2337/dc19-2424. Epub 2020 Mar 31.
3
Sex-specific association between type 1 diabetes and the risk of end-stage renal disease: a systematic review and meta-analysis.
Endocrine. 2020 Jul;69(1):30-38. doi: 10.1007/s12020-020-02255-y. Epub 2020 Mar 12.
4
Sex differences in cardiometabolic disorders.
Nat Med. 2019 Nov;25(11):1657-1666. doi: 10.1038/s41591-019-0643-8. Epub 2019 Nov 7.
5
Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
J Biol Chem. 2019 Nov 1;294(44):16109-16122. doi: 10.1074/jbc.RA119.008966. Epub 2019 Sep 11.
6
Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men.
Diabetes Obes Metab. 2020 Feb;22(2):263-266. doi: 10.1111/dom.13876. Epub 2019 Sep 30.
7
Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes.
Horm Metab Res. 2019 Aug;51(8):487-494. doi: 10.1055/a-0958-2441. Epub 2019 Aug 13.
8
Sex-dependent differences in water homeostasis in wild-type and V-ATPase B1-subunit deficient mice.
PLoS One. 2019 Aug 6;14(8):e0219940. doi: 10.1371/journal.pone.0219940. eCollection 2019.
9
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
Kidney Int. 2019 Oct;96(4):906-917. doi: 10.1016/j.kint.2019.04.024. Epub 2019 May 10.
10
Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants.
BMC Med. 2019 Jul 12;17(1):136. doi: 10.1186/s12916-019-1355-0.
Zotero 插件